Note: Where available, the PDF/Word icon below is provided to view the complete and fully formatted document
 Download Full Day's HansardDownload Full Day's Hansard    View Or Save XMLView/Save XML

Previous Fragment    Next Fragment
Wednesday, 31 May 1972
Page: 3422


Dr Klugman asked the Minister repre senting the Minister for Health, upon notice:

(1)   Has the Minister's attention been drawn to a statement by Dr William McBride deploring the absence of a medical statistician and an expert on congenital malformations from the Drug Evaluation Committee.

(2)   Will he make the appropriate additions to the Committee.


Dr Forbes - The answer to the honourable member's question is as follows:

(1)   I understand that a statement was made by Dr W. G. McBride regarding the absence of an epidemiologist and an expert on congenital malformations on the Australian Drug Evaluation Committee.

(2)   Whilst the formal membership of the Committee does not include such experts, the Committee is empowered to co-opt additional experts in these or any other disciplines, when this is necessary for the performance of its functions.

The honourable member may be interested to know that the Minister recently approved the establishment of a Sub-Committee to investigate and advise him through the Australian Drug Evaluation Committee on all matters relating to drug-associated congenital abnormalities.

The proposed membership of the Congenital Abnormalities Sub-Committee will include a physician, a pharmacologist, a paediatrician, an obstetrician, a teratologist and an epidemiologist.







Suggest corrections